Graeme's

New website

Posted by Graeme in Internet at 12:51 pm on Friday, 13 May 2005

After a very busy week that left me hardly any time for writing, I have split the investment definitions pages off from my investment research site.

Hopefully this will improve usability and make the site more visible in search engines – although the risk is that they may take time to catch up on the change.

Google still has not got page rank flowing through my site five weeks after I changed the URL structure. Yahoo and MSN seem to have been faster at this, but on the other hand Yahoo took much longer to index my whole site in the first place and MSN has still only indexed about 10% of it.

Comments disabled

Music industry fails to get it.

Posted by Graeme in Business & Investment at 1:42 pm on Tuesday, 3 May 2005

Not content with the bad PR of suing customers, or the dubious ethics of sabotaging file sharing (which do have legitimate uses), the recorded music industry has excelled itself by annoying customers and reducing the value of their product simultaneously.
(more…)

Comments disabled

Investors and changing media

Posted by Graeme in Business & Investment at 12:53 pm on Tuesday, 3 May 2005

I have previously written about how the media are changing, but, with most of the benefit likely to go to consumers and individual content creators, the more difficult question is how investors can profit from the change. However there are some areas likely to produce winners:
(more…)

Comments disabled

How the media will change

Posted by Graeme in Business & Investment at 11:32 am on Tuesday, 3 May 2005

I have little doubt that the media will be rapidly changed by technology (primarily the internet and mobile phones), and it is not too difficult to think up the most likely scenarios of that change, however this is a diffiult change for investors to profit from.
(more…)

Comments disabled

Skyepharma – problems solved, price still down

Posted by Graeme in Shares at 12:03 pm on Monday, 2 May 2005

Either the market is simply not prepared to be anything but negative on Skyepharma or I am missing something. The problems with Paxil continue, but Skyepharma has been shielded from the effects of this by a new agreement with Glaxosmithkline’s which gives Skyepharma the royalties on the budgeted sales until normal sales resume.
(more…)

Comments (7)